Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors

This bill allows pharmacists to swap brand-name epinephrine auto-injectors (like EpiPens) with cheaper, equally effective generic versions when a patient is prescribed one. It requires pharmacists to confirm the alternative is less expensive, get the patient’s consent, and provide proper usage instructions. The swap is permitted only if the doctor didn’t specify "dispense as written" on the prescription. This aims to lower costs for patients while ensuring safety through pharmacist counseling.